VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.

As seen in the Kaplan-Meier plots (Figure 3c , 3d ), VE1 appears to have a negative prognostic effect in MMR-deficient patients ( p = 0.0624), although this result did not reach statistical significance, likely due to the small sample size.

also in 111,027 other papers